ArticleJournal of diabetes research2015

Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes.

Tomoko Mizushige et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.